Next Article in Journal
Exploring the Unmet Needs of Teachers of Young Children with ADHD Symptoms: A Qualitative Study
Next Article in Special Issue
Asthma Is an Independent Risk Factor for Acute Chest Syndrome in Children with Sickle Cell Disease in French Guiana
Previous Article in Journal
Risk Factors and 20-Year Time-Trend in Childhood Overweight and Obesity in Switzerland: A Repeated Cross-Sectional Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Experience with Pediatric Chronic Immune Thrombocytopenia over 30 Years in the Era before Eltrombopag

1
Department of Pediatric Hematology and Oncology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul 34696, Turkey
2
Department of Pediatric Hematology and Oncology, Istinye University, Istanbul 34320, Turkey
*
Author to whom correspondence should be addressed.
Children 2024, 11(9), 1051; https://doi.org/10.3390/children11091051
Submission received: 16 July 2024 / Revised: 3 August 2024 / Accepted: 26 August 2024 / Published: 28 August 2024
(This article belongs to the Special Issue Pediatric Blood Diseases and Blood Transfusion Treatment)

Abstract

Background: There is limited information on the natural course of chronic ITP in children. We aimed to evaluate the clinical and demographic characteristics of children with chronic ITP in the era before the availability of eltrombopag. Methods: A total of 86 children with chronic ITP between 1978–2014 were included. Demographic findings, laboratory results, clinical signs, bleeding scores, response time and time of complete remission were recorded. Results: The male/female ratio was 1.09, and median follow-up time was 3 years (range: 1.5–17 years). The median age at diagnosis of chronic ITP was 7 years (range: 2–17), and the median initial platelet count was 10 × 109/L (range: 1–66 × 109/L). Petechiae/ecchymoses were the most common clinical sign (86%) and followed by mucosal bleeding (39.5%). Severe bleeding was seen in 5% of the patients. None of them had intracranial hemorrhage. Twenty patients underwent splenectomy, and the rate of complete remission was 70%. Spontaneous complete remission was seen in 29% of the patients, and the median time to spontaneous complete remission was 3 years. Conclusions: Our study showed that almost one-third of patients with chronic ITP experienced spontaneous complete remission in an average of 3 years, and splenectomy provided satisfactory results in severe cases. This study demonstrates the natural history of chronic ITP in childhood before the era of eltrombopag.
Keywords: children; thrombocytopenia; chronic ITP; splenectomy children; thrombocytopenia; chronic ITP; splenectomy

Share and Cite

MDPI and ACS Style

Koc, B.S.; Ozdemir, G.N.; Alakbarli, J.; Apak, H.; Celkan, T. Experience with Pediatric Chronic Immune Thrombocytopenia over 30 Years in the Era before Eltrombopag. Children 2024, 11, 1051. https://doi.org/10.3390/children11091051

AMA Style

Koc BS, Ozdemir GN, Alakbarli J, Apak H, Celkan T. Experience with Pediatric Chronic Immune Thrombocytopenia over 30 Years in the Era before Eltrombopag. Children. 2024; 11(9):1051. https://doi.org/10.3390/children11091051

Chicago/Turabian Style

Koc, Begum S., Gul Nihal Ozdemir, Javid Alakbarli, Hilmi Apak, and Tiraje Celkan. 2024. "Experience with Pediatric Chronic Immune Thrombocytopenia over 30 Years in the Era before Eltrombopag" Children 11, no. 9: 1051. https://doi.org/10.3390/children11091051

APA Style

Koc, B. S., Ozdemir, G. N., Alakbarli, J., Apak, H., & Celkan, T. (2024). Experience with Pediatric Chronic Immune Thrombocytopenia over 30 Years in the Era before Eltrombopag. Children, 11(9), 1051. https://doi.org/10.3390/children11091051

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop